A detailed history of Keebeck Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Keebeck Wealth Management, LLC holds 1,622 shares of AMGN stock, worth $512,552. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,622
Previous 1,646 1.46%
Holding current value
$512,552
Previous $467,000 8.35%
% of portfolio
0.08%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $6,306 - $7,663
-24 Reduced 1.46%
1,622 $506,000
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $4,033 - $4,868
15 Added 0.92%
1,646 $467,000
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $17,387 - $19,615
68 Added 4.35%
1,631 $469,000
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $5,466 - $6,786
25 Added 1.63%
1,563 $420,000
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $5,356 - $6,334
25 Added 1.65%
1,538 $341,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $9,483 - $11,558
42 Added 2.86%
1,513 $365,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $3,435 - $4,365
15 Added 1.03%
1,471 $386,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $17,103 - $19,573
86 Added 6.28%
1,456 $328,000
Q3 2021

Nov 16, 2021

SELL
$212.27 - $248.7 $1,910 - $2,238
-9 Reduced 0.65%
1,370 $291,000
Q3 2020

Nov 02, 2020

BUY
$234.65 - $260.95 $4,927 - $5,479
21 Added 1.55%
1,379 $350,000
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $147,614 - $195,777
810 Added 147.81%
1,358 $275,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $103,687 - $133,273
548 New
548 $132,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Keebeck Wealth Management, LLC Portfolio

Follow Keebeck Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Wealth Management, LLC with notifications on news.